Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 9021-9030 of 13441

Page
per page
  1. CW069
    B3062 CW069
    Summary: allosteric inhibitor of HSET, selective
      ≥50 mg/mL
  2. MM-102
    B1582 MM-102
     1 Citation
    Summary: MLL1 inhibitor,high-affinity peptidomimetic
  3. Golvatinib (E7050)
    B1439 Golvatinib (E7050)
    Target: VEGFR
    Summary: C-Met/VEGFR-2 inhibitor
  4. Dihydroeponemycin
    A8172 Dihydroeponemycin
     1 Citation
    Summary: Proteasome inhibitor,antitumor reagent,eponemycin ddrivative
      ≥15.6 mg/mL
  5. NS 11394
    B6102 NS 11394
    Summary: GABA(A) receptor-positive modulator
      ≥35.3 mg/mL
  6. Losartan Carboxylic Acid
    C3065 Losartan Carboxylic Acid
    Summary: AT1 antagonist
      ≤30 mg/mL
  7. BCATc Inhibitor 2
    C3463 BCATc Inhibitor 2
    Summary: cytosolic BCAT (BCATc) inhibitor
      ≤10 mg/mL
  8. N-Oxalylglycine
    C3095 N-Oxalylglycine
    Summary: cell permeable inhibitor of α-ketoglutarate-dependent enzymes, including JMJD2A, JMJD2C, and JMJD2E.
      insoluble in EtOH; ≥3.82 mg/mL
  9. FPS-ZM1
    C3723 FPS-ZM1
    Summary: RAGE Inhibitor
  10. MMP Inhibitor II
    C4081 MMP Inhibitor II
    Summary: MMPs inhibitor
      ≤0.5 mg/mL

Items 9021-9030 of 13441

Page
per page